As of 2025-03-19, the Relative Valuation of Krystal Biotech Inc (KRYS) is 149.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 188.50 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -20.9%.
The range of the Relative Valuation is 109.67 - 176.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 45.7x - 57.1x | 51.4x |
| Forward P/E multiples | 42.7x - 65.6x | 54.2x |
| Fair Price | 109.67 - 176.71 | 149.14 |
| Upside | -41.8% - -6.3% | -20.9% |
| Date | P/E |
| 2025-03-17 | 57.95 |
| 2025-03-14 | 57.96 |
| 2025-03-13 | 57.31 |
| 2025-03-12 | 57.64 |
| 2025-03-11 | 59.74 |
| 2025-03-10 | 59.38 |
| 2025-03-07 | 58.14 |
| 2025-03-06 | 57.82 |
| 2025-03-05 | 58.18 |
| 2025-03-04 | 56.62 |
| 2025-03-03 | 55.52 |
| 2025-02-28 | 57.92 |
| 2025-02-27 | 56.01 |
| 2025-02-26 | 57.00 |
| 2025-02-25 | 58.52 |
| 2025-02-24 | 60.39 |
| 2025-02-21 | 60.70 |
| 2025-02-20 | 59.01 |
| 2025-02-19 | 56.93 |
| 2025-02-18 | 50.63 |
| 2025-02-14 | 49.52 |
| 2025-02-13 | 50.33 |
| 2025-02-12 | 48.90 |
| 2025-02-11 | 48.44 |
| 2025-02-10 | 49.93 |
| 2025-02-07 | 50.04 |
| 2025-02-06 | 52.04 |
| 2025-02-05 | 52.49 |
| 2025-02-04 | 52.12 |
| 2025-02-03 | 51.39 |
| 2025-01-31 | 51.62 |
| 2025-01-30 | 50.43 |
| 2025-01-29 | 50.51 |
| 2025-01-28 | 51.44 |
| 2025-01-27 | 51.40 |
| 2025-01-24 | 50.02 |
| 2025-01-23 | 50.10 |
| 2025-01-22 | 49.59 |
| 2025-01-21 | 48.97 |
| 2025-01-17 | 47.95 |
| 2025-01-16 | 46.79 |
| 2025-01-15 | 47.32 |
| 2025-01-14 | 46.09 |
| 2025-01-13 | 48.57 |
| 2025-01-10 | 49.41 |
| 2025-01-08 | 50.62 |
| 2025-01-07 | 51.62 |
| 2025-01-06 | 50.35 |
| 2025-01-03 | 51.16 |
| 2025-01-02 | 50.57 |